These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3363275)

  • 21. Retinopathy in preeclampsia: association with birth weight and uric acid level.
    Gupta A; Kaliaperumal S; Setia S; Suchi ST; Rao VA
    Retina; 2008 Oct; 28(8):1104-10. PubMed ID: 18779717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early fetal growth retardation: obstetric background and recurrence rate.
    Visser GH; Huisman A; Saathof PW; Sinnige HA
    Obstet Gynecol; 1986 Jan; 67(1):40-3. PubMed ID: 3940335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of plasma uric acid in pregnancy induced hypertension (PIH). Is the test still relevant?
    Wakwe VC; Abudu OO
    Afr J Med Med Sci; 1999; 28(3-4):155-8. PubMed ID: 11205821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic parameters of maternal amino acid metabolism and fetal growth.
    Hod M; Lapidot A
    Isr J Med Sci; 1996 Jul; 32(7):530-6. PubMed ID: 8756979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal outcome in growth-restricted fetuses: do hypertensive and normotensive pregnancies differ?
    Piper JM; Langer O; Xenakis EM; McFarland M; Elliott BD; Berkus MD
    Obstet Gynecol; 1996 Aug; 88(2):194-9. PubMed ID: 8692500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic.
    Lydakis C; Beevers M; Beevers DG; Lip GY
    Int J Clin Pract; 2001; 55(6):361-7. PubMed ID: 11501223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arterial hypertension and pregnancy].
    Uzan S; Merviel P; Beaufils M
    Rev Prat; 1995 Sep; 45(14):1766-70. PubMed ID: 7494963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dihydralazine on the fetus in the treatment of maternal hypertension.
    Vink GJ; Moodley J; Philpott RH
    Obstet Gynecol; 1980 Apr; 55(4):519-22. PubMed ID: 7366909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy.
    Howarth C; Gazis A; James D
    Diabet Med; 2007 Nov; 24(11):1229-34. PubMed ID: 17725628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy.
    Aardenburg R; Spaanderman ME; Ekhart TH; van Eijndhoven HW; van der Heijden OW; Peeters LL
    BJOG; 2003 Nov; 110(11):1001-6. PubMed ID: 14592585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum uric acid as a prognostic parameter in prenatal monitoring of gestoses].
    Müller U; Link M; Bellée H; Mühlbach F
    Zentralbl Gynakol; 1983; 105(10):629-34. PubMed ID: 6880464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between plasma renin activity and birth weight in hypertensive pregnancy.
    Taufield PA; Druzin ML; Edersheim TE; Sealey JE; Laragh JH
    J Hypertens Suppl; 1986 Dec; 4(5):S96-8. PubMed ID: 3553491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertension and pregnancy. Diagnosis, physiopathology and treatment].
    Fournier A; Fievet P; el Esper I; el Esper N; Vaillant P; Gondry J
    Schweiz Med Wochenschr; 1995 Nov; 125(47):2273-98. PubMed ID: 8539576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester.
    Leung TY; Sahota DS; Chan LW; Law LW; Fung TY; Leung TN; Lau TK
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birth weight percentile and perinatal outcome: recurrence of intrauterine growth retardation.
    Patterson RM; Gibbs CE; Wood RC
    Obstet Gynecol; 1986 Oct; 68(4):464-8. PubMed ID: 3748492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of hypertensive disease of pregnancy on intrauterine growth retardation].
    Molina M; Casanueva V; Pérez R; Ferrada C; Cisternas J; Cid L; Sáez K
    Rev Med Chil; 1998 Apr; 126(4):375-82. PubMed ID: 9699367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma renin activity, blood uric acid and plasma volume in pregnancy-induced hypertension.
    Fievet P; Pleskov L; Desailly I; Carayon A; de Fremont JF; Coevoet B; Comoy E; Demory JE; Verhoest P; Boulanger JC
    Nephron; 1985; 40(4):429-32. PubMed ID: 3895007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The cardiovascular paradox of pregnancy].
    St-Louis J; Brochu M
    Med Sci (Paris); 2007 Nov; 23(11):944-9. PubMed ID: 18021705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma volume and its effect on the fate of the fetus in pregnancy complicated by hypertension].
    Kuźniar J; Piela A; Skret A; Szmigiel Z; Palczak R; Rybak A
    Ginekol Pol; 1987 Apr; 58(4):248-53. PubMed ID: 3653745
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporin requirement during pregnancy in renal transplant recipients.
    Biesenbach G; Zazgornik J; Kaiser W; Stöger H; Derfler K; Balcke P; Hauser C
    Nephrol Dial Transplant; 1989; 4(7):667-9. PubMed ID: 2510067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.